<!DOCTYPE html
  PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:n1="urn:hl7-org:v3">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
   
      <title>Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular
         Systolic Dysfunction (LVSD)
      </title><style type="text/css">
body {
	color: rgb(26, 26, 26);
	background-color: rgb(255,255,255);
	font-family: Verdana, Tahoma, sans-serif;
	font-size: 11px;
}

a {
	color: rgb(0, 0, 255);
	background-color: rgb(255,255,255);
}

h1 {
	font-size: 12pt;
	font-weight: bold;
}

h2 {
	font-size: 11pt;
	font-weight: bold;
}

h3 {
	font-size: 10pt;
	font-weight: bold;
}

h4 {
	font-size: 8pt;
	font-weight: bold;
}

div {
	width: 80%;
}

table {
	line-height: 10pt;
	width: 80%;
}

tr {
	background-color: rgb(224,224,224);
}

td {
	padding: 0.1cm 0.2cm;
	vertical-align: top;
}

.h1center {
	font-size: 12pt;
	font-weight: bold;
	text-align: center;
	width: 80%;
}

.header_table{
	border: 1pt inset rgb(0,0,0);
}

.narr_table {
	width: 100%;
}

.narr_tr {
	background-color: rgb(225,225,225);
}
pre {
 overflow: auto; /* Use horizontal scroller if needed; for Firefox 2, not needed in Firefox 3 */
 white-space: pre-wrap; /* css-3 */
 white-space: -moz-pre-wrap !important; /* Mozilla, since 1999 */
 white-space: -pre-wrap; /* Opera 4-6 */
 white-space: -o-pre-wrap; /* Opera 7 */
 word-wrap: break-word; /* Internet Explorer 5.5+ */
 font-family: Verdana, Tahoma, sans-serif;
 font-size: 11px;
 text-align:left;
 margin: 0px 0px 0px 0px;
 padding:0px 0px 0px 0px;
}
.narr_th {
	background-color: rgb(201,201,201);
}

.td_label{
	font-weight: bold;
	color: white;
}
	</style></head>
   <body>
      <table class="header_table">
         <tbody>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Title</span></td>
               <td width="80%" colspan="3">Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular
                  Systolic Dysfunction (LVSD)
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Identifier<br>(Measure Authoring Tool)</span></td>
               <td width="30%">135</td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Version number</span></td>
               <td width="30%">1</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">NQF Number</span></td>
               <td width="30%">0081</td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">GUID</span></td>
               <td> 430ffc53-4122-4421-88cc-2edd8117bb3c</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measurement Period</span></td>
               <td width="80%" colspan="3">January 1, 20xx  through December 31, 20xx </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Steward</span></td>
               <td width="80%" colspan="3">American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Developer</span></td>
               <td width="80%" colspan="3">American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Endorsed By</span></td>
               <td width="80%" colspan="3">National Quality Forum</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Description</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) &lt; 40% who were prescribed ACE inhibitor or ARB therapy either within a 12 month period when seen in the outpatient setting OR at each hospital discharge</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Copyright</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Copyright 2012 American College of Cardiology, American Heart Association and American Medical Association. All Rights Reserved.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Disclaimer</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Physician Performance Measures (Measures) and related data specifications have been developed by the American Medical Association (AMA) - convened Physician Consortium for Performance Improvement(R) (the PCPI[TM]), American College of Cardiology (ACC) and American Heart Association (AHA). These Measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications. The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the Measures require a license agreement between the user and the AMA, (on behalf of the PCPI), ACC or AHA. Neither the AMA, ACC, AHA, PCPI nor its members shall be responsible for any use of the Measures. 

THE MEASURES AND SPECIFICATIONS ARE PROVIDED &#8220;AS IS&#8221; WITHOUT WARRANTY OF ANY KIND. 

Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, ACC, AHA, the PCPI and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT[R]) or other coding contained in the specifications. 

CPT(R) contained in the Measure specifications is copyright 2004-2011 American Medical Association. LOINC(R) copyright 2004-2011 Regenstrief Institute, Inc. 

This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2011 International Health Terminology Standards Development Organisation. ICD-10 copyright 2011 World Health Organization. All Rights Reserved.

Due to technical limitations, registered trademarks are indicated by (R) or [R] and unregistered trademarks are indicated by (TM) or [TM]</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Scoring</span></td>
               <td width="80%" colspan="3">Proportion</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Type</span></td>
               <td width="80%" colspan="3">Process</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Stratification</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Risk Adjustment</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Rate Aggregation</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Rationale</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>In the absence of contraindications, ACE inhibitors or ARBs are recommended for all patients with symptoms of heart failure and reduced left ventricular systolic function. ACE inhibitors remain the first choice for inhibition of the renin-angiotensin system in chronic heart failure, but ARBs can now be considered a reasonable alternative. Both pharmacologic agents have been shown to decrease the risk of death and hospitalization. Additional benefits of ACE inhibitors include the alleviation of symptoms and the improvement of clinical status and overall sense of well-being of patients with heart failure.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Clinical Recommendation Statement</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Angiotensin converting enzyme inhibitors are recommended for all patients with current or prior symptoms of [heart failure] and reduced LVEF, unless contraindicated (Class I, Level of Evidence: A) (ACCF/AHA,2009).

Treatment with an [ACE inhibitor] should be initiated at low doses [see excerpt from guideline table below], followed by gradual increments in dose if lower doses have been well tolerated&#8230; Clinicians should attempt to use doses that have been shown to reduce the risk of cardiovascular events in clinical trials. If these target doses of an [ACEinhibitor] cannot be used or are poorly tolerated, intermediate doses should be used with the expectation that there are likely to be only small differences in efficacy between low and high doses. (ACCF/AHA, 2009)

Inhibitors of the Renin-Angiotensin-Aldosterone System &#8230;Commonly Used for the
Treatment of Patients with [Heart Failure] with Low Ejection Fraction
Drug                       Initial Daily Dose(s)                             Maximum Doses(s)
ACE Inhibitors
  Captopril               6.25 mg 3 times                                50 mg 3 times
   Enalapril               2.5 mg twice                                    10 to 20 mg twice
   Fosinopril             5 to 10 mg once                                40 mg once
   Lisinopril              2.5 to 5 mg once                               20 to 40 mg once
   Perindopril           2 mg once                                        8 to 16 mg once
   Quinapril              5 mg twice                                       20 mg twice
   Ramipril               1.25 to 2.5 mg once                          10 mg once
   Trandolapril          1 mg once                                        4 mg once
Angiotensin Receptor Blockers
   Candesartan           4 to 8 mg once                                 32 mg once
   Losartan**             25 to 50 mg once                              50 to 100 mg once
   Valsartan               20 to 40 mg twice                             160 mg twice

**[Note: Among ARBs, Losartan has the weakest evidence supporting its value in heart failure patients. Additionally, while the 2009 guidelines recommended a maximum dosage of 100mg, the maximum dosage recommendation for Losartan has been increased to 150mg based on the HEAAL trial(Konstam et al. 2009)

An ARB should be administered to post-[myocardial infarction (MI)] patients without [heart failure] who are intolerant of [ACE inhibitors] and have a low LVEF (Class I, Level of Evidence: B) (ACCF/AHA, 2009)

Angiotensin II receptor blockers are reasonable to use as alternatives to [ACE inhibitors] as first-line therapy for patients with mild to moderate [heart failure] and reduced LVEF, especially for patients already taking ARBs for other indications (Class IIa, Level of Evidence: A) (ACCF/AHA, 2009)

For the hospitalized patient:
--In patients with reduced ejection fraction experiencing a symptomatic exacerbation of [heart failure] requiring hospitalization during chronic maintenance treatment with oral therapies known to improve outcomes, particularly ACE inhibitors or ARBs and betablocker therapy, it is recommended that these therapies be continued in most patients in the absence of hemodynamic instability or contraindications. (Class I, Level of Evidence: C) (ACCF/AHA, 2009)
--In patients hospitalized with [heart failure] with reduced ejection fraction not treated with oral therapies known to improve outcomes, particularly ACE inhibitors or ARBs and beta-blocker therapy, initiation of these therapies is recommended in stable patients prior to hospital discharge. Initiation of beta-blocker therapy is recommended after optimization of volume status and successful discontinuation of intravenous diuretics, vasodilators, and inotropic agents. Beta-blocker therapy should be initiated at a low dose
and only in stable patients. Particular caution should be used when initiating betablockers in patients who have required inotropes during their hospital course. (Class I, Level of Evidence: B) (ACCF/AHA,2009)</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Improvement Notation</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Higher score indicates better quality</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Jessup M, Abraham WT, Casey DE, et al., writing on behalf of the 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult Writing Committee. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009;53:1343&#8211; 82.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Konstam MA, Neaton JD, Dickstein K, Drexler H, Komajda M, Martinez FA, Riegger GA, Malbecq W, Smith RD, Guptha S, Poole-Wilson PA. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial. Lancet 2009 Nov 28;374:1840-8</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Outpatient setting: prescription given to the patient for ACE inhibitor or ARB therapy at one or more visits in the measurement period OR patient already taking ACE inhibitor or ARB therapy as documented in current medication list.

Inpatient setting: prescription given to the patient for ACE inhibitor or ARB therapy at discharge OR ACE inhibitor or ARB therapy to be continued after discharge as documented in the discharge medication list.

LVEF &lt; 40% corresponds to qualitative documentation of moderate dysfunction or severe dysfunction.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Guidance</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>To meet this measure, it must be reported for all heart failure patients a minimum of once during the measurement period when seen in the outpatient setting AND reported at each hospital discharge during the measurement period.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Transmission Format</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>TBD</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Initial Patient Population</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>All patients aged 18 years and older with a diagnosis of heart failure</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Denominator</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Equals Initial Patient Population with a current or prior LVEF &lt; 40%</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Denominator Exclusions</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Numerator</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Patients who were prescribed ACE inhibitor or ARB therapy either within a 12 month period when seen in the outpatient setting or at hospital discharge</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Numerator Exclusions</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Not Applicable</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Denominator Exceptions</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Documentation of medical reason(s) for not prescribing ACE inhibitor or ARB therapy (e.g., hypotensive patients who are at immediate risk of cardiogenic shock, hospitalized patients who have experienced marked azotemia, allergy, intolerance, other medical reasons)
Documentation of patient reason(s) for not prescribing ACE inhibitor or ARB therapy (e.g., patient declined, other patient reasons)
Documentation of system reason(s) for not prescribing ACE inhibitor or ARB therapy (e.g., other system reasons)</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Population</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Not Applicable</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Observations</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Not Applicable</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Supplemental Data Elements</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>For every patient evaluated by this measure also identify payer, race, ethnicity and sex.</pre></div>
               </td>
            </tr>
         </tbody>
      </table>
      <h2><a name="toc">Table of Contents</a></h2>
      <ul>
         <li><a href="#d2399176e475">Population criteria</a></li>
         <li><a href="#d2399176e3529">Data criteria (QDM Data Elements)</a></li>
         <li><a href="#d2399176e4667">Reporting Stratification</a></li>
         <li><a href="#d2399176e4688">Supplemental Data Elements</a></li>
      </ul>
      <hr align="left" color="teal" size="2" width="80%">
      <h3><a name="d2399176e475" href="#toc">Population criteria</a></h3>
      <div>
         
         <ul>
            <li>
               <b>Initial Patient Population =</b>
               
               <ul>
                  <li>AND: "Patient Characteristic Birthdate: birth date"  &gt;= 18 year(s) starts before start of "Measurement Period"</li>
                  <li>AND: "Diagnosis, Active: Heart Failure" starts before or during 
                     <ul>
                        <li>OR: "Occurrence A of Encounter, Performed: Care Services in Long-Term Residential Facility"</li>
                        <li>OR: "Occurrence A of Encounter, Performed: Discharge Services - Hospital Inpatient"</li>
                        <li>OR: "Occurrence A of Encounter, Performed: Home Healthcare Services"</li>
                        <li>OR: "Occurrence A of Encounter, Performed: Nursing Facility Visit"</li>
                        <li>OR: "Occurrence A of Encounter, Performed: Office Visit"</li>
                        <li>OR: "Occurrence A of Encounter, Performed: Outpatient Consultation"</li>
                        <li>OR: "Occurrence A of Encounter, Performed: Face-to-Face Interaction"</li>
                        <li> during "Measurement Period"</li>
                     </ul>
                     
                  </li>
                  <li>AND: 
                     <ul>
                        <li>OR: Count &gt;= 2  of:
                           <ul>
                              <li>OR: "Encounter, Performed: Care Services in Long-Term Residential Facility"</li>
                              <li>OR: "Encounter, Performed: Home Healthcare Services"</li>
                              <li>OR: "Encounter, Performed: Nursing Facility Visit"</li>
                              <li>OR: "Encounter, Performed: Office Visit"</li>
                              <li>OR: "Encounter, Performed: Outpatient Consultation"</li>
                              <li>OR: "Encounter, Performed: Patient Provider Interaction"</li>
                           </ul>
                           
                        </li>
                        <li>OR: "Encounter, Performed: Discharge Services - Hospital Inpatient"</li>
                        <li> during "Measurement Period"</li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Denominator =</b>
               
               <ul>
                  <li>AND: "Initial Patient Population"</li>
                  <li>AND: 
                     <ul>
                        <li>OR: "Diagnostic Study, Result: Ejection Fraction (result &lt; 40 %)"</li>
                        <li>OR: "Diagnosis, Active: Moderate or Severe LVSD"</li>
                        <li>OR: "Diagnosis, Active: Left ventricular systolic dysfunction (severity: 'moderate or severe')"</li>
                        <li> starts before or during 
                           <ul>
                              <li>OR: "Occurrence A of Encounter, Performed: Care Services in Long-Term Residential Facility"</li>
                              <li>OR: "Occurrence A of Encounter, Performed: Discharge Services - Hospital Inpatient"</li>
                              <li>OR: "Occurrence A of Encounter, Performed: Home Healthcare Services"</li>
                              <li>OR: "Occurrence A of Encounter, Performed: Nursing Facility Visit"</li>
                              <li>OR: "Occurrence A of Encounter, Performed: Office Visit"</li>
                              <li>OR: "Occurrence A of Encounter, Performed: Outpatient Consultation"</li>
                              <li>OR: "Occurrence A of Encounter, Performed: Face-to-Face Interaction"</li>
                           </ul>
                           
                        </li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Denominator Exclusions =</b>
               
               <ul>
                  <li>None</li>
               </ul>
               
            </li>
            <li>
               <b>Numerator =</b>
               
               <ul>
                  <li>AND: 
                     <ul>
                        <li>OR: "Medication, Order: ACE inhibitor or ARB" during 
                           <ul>
                              <li>OR: "Occurrence A of Encounter, Performed: Care Services in Long-Term Residential Facility"</li>
                              <li>OR: "Occurrence A of Encounter, Performed: Discharge Services - Hospital Inpatient"</li>
                              <li>OR: "Occurrence A of Encounter, Performed: Home Healthcare Services"</li>
                              <li>OR: "Occurrence A of Encounter, Performed: Nursing Facility Visit"</li>
                              <li>OR: "Occurrence A of Encounter, Performed: Office Visit"</li>
                              <li>OR: "Occurrence A of Encounter, Performed: Outpatient Consultation"</li>
                              <li>OR: "Occurrence A of Encounter, Performed: Face-to-Face Interaction"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND NOT: "Occurrence A of Medication, Active: ACE inhibitor or ARB" ends before start of "Occurrence A of Encounter, Performed:
                                 Care Services in Long-Term Residential Facility"
                              </li>
                              <li>AND: "Occurrence A of Medication, Active: ACE inhibitor or ARB" starts before or during "Occurrence A of Encounter, Performed:
                                 Care Services in Long-Term Residential Facility"
                              </li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND NOT: "Occurrence A of Medication, Active: ACE inhibitor or ARB" ends before start of "Occurrence A of Encounter, Performed:
                                 Discharge Services - Hospital Inpatient"
                              </li>
                              <li>AND: "Occurrence A of Medication, Active: ACE inhibitor or ARB" starts before or during "Occurrence A of Encounter, Performed:
                                 Discharge Services - Hospital Inpatient"
                              </li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND NOT: "Occurrence A of Medication, Active: ACE inhibitor or ARB" ends before start of "Occurrence A of Encounter, Performed:
                                 Home Healthcare Services"
                              </li>
                              <li>AND: "Occurrence A of Medication, Active: ACE inhibitor or ARB" starts before or during "Occurrence A of Encounter, Performed:
                                 Home Healthcare Services"
                              </li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND NOT: "Occurrence A of Medication, Active: ACE inhibitor or ARB" ends before start of "Occurrence A of Encounter, Performed:
                                 Nursing Facility Visit"
                              </li>
                              <li>AND: "Occurrence A of Medication, Active: ACE inhibitor or ARB" starts before or during "Occurrence A of Encounter, Performed:
                                 Nursing Facility Visit"
                              </li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND NOT: "Occurrence A of Medication, Active: ACE inhibitor or ARB" ends before start of "Occurrence A of Encounter, Performed:
                                 Outpatient Consultation"
                              </li>
                              <li>AND: "Occurrence A of Medication, Active: ACE inhibitor or ARB" starts before or during "Occurrence A of Encounter, Performed:
                                 Outpatient Consultation"
                              </li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND NOT: "Occurrence A of Medication, Active: ACE inhibitor or ARB" ends before start of "Occurrence A of Encounter, Performed:
                                 Office Visit"
                              </li>
                              <li>AND: "Occurrence A of Medication, Active: ACE inhibitor or ARB" starts before or during "Occurrence A of Encounter, Performed:
                                 Office Visit"
                              </li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND NOT: "Occurrence A of Medication, Active: ACE inhibitor or ARB" ends before start of "Occurrence A of Encounter, Performed:
                                 Face-to-Face Interaction"
                              </li>
                              <li>AND: "Occurrence A of Medication, Active: ACE inhibitor or ARB" starts before or during "Occurrence A of Encounter, Performed:
                                 Face-to-Face Interaction"
                              </li>
                           </ul>
                           
                        </li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Denominator Exceptions =</b>
               
               <ul>
                  <li>AND: 
                     <ul>
                        <li>OR: 
                           <ul>
                              <li>OR: "Medication, Order not done: Medical Reason" for "ACE inhibitor or ARB Grouping Value Set"</li>
                              <li>OR: "Medication, Order not done: Patient Reason" for "ACE inhibitor or ARB Grouping Value Set"</li>
                              <li>OR: "Medication, Order not done: System Reason" for "ACE inhibitor or ARB Grouping Value Set"</li>
                              <li>OR: "Communication: From Patient to Provider: Patient reason for ACE inhibitor or ARB decline"</li>
                              <li> during "Measurement Period"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>OR: "Medication, Allergy: ACE inhibitor or ARB"</li>
                              <li>OR: "Diagnosis, Active: Allergy to ACE inhibitor or ARB"</li>
                              <li>OR: "Medication, Intolerance: ACE inhibitor or ARB"</li>
                              <li>OR: "Diagnosis, Active: Intolerance to ACE inhibitor or ARB"</li>
                              <li>OR: "Diagnosis, Active: Pregnancy"</li>
                              <li>OR: "Diagnosis, Active: Renal Failure Due to ACE Inhibitor"</li>
                              <li> starts before or during 
                                 <ul>
                                    <li>OR: "Occurrence A of Encounter, Performed: Care Services in Long-Term Residential Facility"</li>
                                    <li>OR: "Occurrence A of Encounter, Performed: Discharge Services - Hospital Inpatient"</li>
                                    <li>OR: "Occurrence A of Encounter, Performed: Home Healthcare Services"</li>
                                    <li>OR: "Occurrence A of Encounter, Performed: Nursing Facility Visit"</li>
                                    <li>OR: "Occurrence A of Encounter, Performed: Office Visit"</li>
                                    <li>OR: "Occurrence A of Encounter, Performed: Outpatient Consultation"</li>
                                    <li>OR: "Occurrence A of Encounter, Performed: Face-to-Face Interaction"</li>
                                 </ul>
                                 
                              </li>
                           </ul>
                           
                        </li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
         </ul>
         
      </div>
      <h3><a name="d2399176e3529" href="#toc">Data criteria (QDM Data Elements)</a></h3>
      <div>
         
         <ul>
            <li>
               "Communication: From Patient to Provider: Patient reason for ACE inhibitor or ARB decline" using "Patient reason for ACE inhibitor or ARB decline Grouping Value Set (2.16.840.1.113883.3.526.3.1140)"
            </li>
            <li>
               "Diagnosis, Active: Allergy to ACE inhibitor or ARB" using "Allergy to ACE inhibitor or ARB Grouping Value Set (2.16.840.1.113883.3.526.3.1211)"
            </li>
            <li>
               "Diagnosis, Active: Heart Failure" using "Heart Failure Grouping Value Set (2.16.840.1.113883.3.526.3.376)"
            </li>
            <li>
               "Diagnosis, Active: Intolerance to ACE inhibitor or ARB" using "Intolerance to ACE inhibitor or ARB Grouping Value Set (2.16.840.1.113883.3.526.3.1212)"
            </li>
            <li>
               "Diagnosis, Active: Left ventricular systolic dysfunction" using "Left ventricular systolic dysfunction Grouping Value Set (2.16.840.1.113883.3.526.3.1091)"
            </li>
            <li>
               "Diagnosis, Active: Moderate or Severe LVSD" using "Moderate or Severe LVSD Grouping Value Set (2.16.840.1.113883.3.526.3.1090)"
            </li>
            <li>
               "Diagnosis, Active: Pregnancy" using "Pregnancy Grouping Value Set (2.16.840.1.113883.3.526.3.378)"
            </li>
            <li>
               "Diagnosis, Active: Renal Failure Due to ACE Inhibitor" using "Renal Failure Due to ACE Inhibitor Grouping Value Set (2.16.840.1.113883.3.526.3.1151)"
            </li>
            <li>
               "Diagnostic Study, Result: Ejection Fraction" using "Ejection Fraction Grouping Value Set (2.16.840.1.113883.3.526.3.1134)"
            </li>
            <li>
               "Encounter, Performed: Care Services in Long-Term Residential Facility" using "Care Services in Long-Term Residential Facility Grouping Value Set (2.16.840.1.113883.3.464.1003.101.12.1014)"
            </li>
            <li>
               "Encounter, Performed: Discharge Services - Hospital Inpatient" using "Discharge Services - Hospital Inpatient Grouping Value Set (2.16.840.1.113883.3.464.1003.101.12.1007)"
            </li>
            <li>
               "Encounter, Performed: Face-to-Face Interaction" using "Face-to-Face Interaction Grouping Value Set (2.16.840.1.113883.3.464.1003.101.12.1048)"
            </li>
            <li>
               "Encounter, Performed: Home Healthcare Services" using "Home Healthcare Services Grouping Value Set (2.16.840.1.113883.3.464.1003.101.12.1016)"
            </li>
            <li>
               "Encounter, Performed: Nursing Facility Visit" using "Nursing Facility Visit Grouping Value Set (2.16.840.1.113883.3.464.1003.101.12.1012)"
            </li>
            <li>
               "Encounter, Performed: Office Visit" using "Office Visit Grouping Value Set (2.16.840.1.113883.3.464.1003.101.12.1001)"
            </li>
            <li>
               "Encounter, Performed: Outpatient Consultation" using "Outpatient Consultation Grouping Value Set (2.16.840.1.113883.3.464.1003.101.12.1008)"
            </li>
            <li>
               "Encounter, Performed: Patient Provider Interaction" using "Patient Provider Interaction Grouping Value Set (2.16.840.1.113883.3.526.3.1012)"
            </li>
            <li>
               "Medication, Active: ACE inhibitor or ARB" using "ACE inhibitor or ARB Grouping Value Set (2.16.840.1.113883.3.526.3.1139)"
            </li>
            <li>
               "Medication, Allergy: ACE inhibitor or ARB" using "ACE inhibitor or ARB Grouping Value Set (2.16.840.1.113883.3.526.3.1139)"
            </li>
            <li>
               "Medication, Intolerance: ACE inhibitor or ARB" using "ACE inhibitor or ARB Grouping Value Set (2.16.840.1.113883.3.526.3.1139)"
            </li>
            <li>
               "Medication, Order: ACE inhibitor or ARB" using "ACE inhibitor or ARB Grouping Value Set (2.16.840.1.113883.3.526.3.1139)"
            </li>
            <li>
               "Medication, Order not done: Medical Reason" using "Medical Reason Grouping Value Set (2.16.840.1.113883.3.526.3.1007)"
            </li>
            <li>
               "Medication, Order not done: Patient Reason" using "Patient Reason Grouping Value Set (2.16.840.1.113883.3.526.3.1008)"
            </li>
            <li>
               "Medication, Order not done: System Reason" using "System Reason Grouping Value Set (2.16.840.1.113883.3.526.3.1009)"
            </li>
            <li>
               "Patient Characteristic Birthdate: birth date" using "birth date LOINC Value Set (2.16.840.1.113883.3.560.100.4)"
            </li>
            <li>
               Attribute: "Severity: Moderate or severe" using "Moderate or severe Grouping Value Set  (2.16.840.1.113883.3.526.3.1092)"
            </li>
         </ul>
         
      </div>
      <h3><a name="d2399176e4667" href="#toc">Reporting Stratification</a></h3>
      <div>
         
         <ul>
            <li>None</li>
         </ul>
         
      </div>
      <h3><a name="d2399176e4688" href="#toc">Supplemental Data Elements</a></h3>
      <div>
         
         <ul>
            <li>
               "Patient Characteristic Ethnicity: Ethnicity" using "Ethnicity CDC Value Set (2.16.840.1.114222.4.11.837)"
            </li>
            <li>
               "Patient Characteristic Payer: Payer" using "Payer Source of Payment Typology Value Set (2.16.840.1.114222.4.11.3591)"
            </li>
            <li>
               "Patient Characteristic Race: Race" using "Race CDC Value Set (2.16.840.1.114222.4.11.836)"
            </li>
            <li>
               "Patient Characteristic Sex: ONC Administrative Sex" using "ONC Administrative Sex Administrative Sex Value Set (2.16.840.1.113762.1.4.1)"
            </li>
         </ul>
         
      </div><br><hr align="left" color="teal" size="2" width="80%"><br><table class="header_table">
         <tbody>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Set</span></td>
               <td colspan="3" width="80%">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto;word-wrap:break-word">None</div>
               </td>
            </tr>
         </tbody>
      </table>
   </body>
</html>